Sheha et al [58, 59] found that dyslipidemia was prevalent in 56% of AR patient in their study, and higher serum total IgE, IL-17A level were independent risk factors for dyslipidemia among AR patients. The gene discussed is IGHE; the disease is metabolic syndrome.